Bio-Rad

FDA Regulatory Profile

Bio-Rad has 0 FDA recalls, 3 inspections, 319 510(k) clearances and 0 compliance actions on record.

Latest inspection
May 16, 2025 · VAI
Latest 510(k)
Dec 28, 2017

Reviewing Bio-Rad as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Bio-Rad yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Summary

Record counts and when each FDA source was last refreshed
RecordsCountLast refreshedSource as ofStatus
Recalls0Nov 8, 2026File dated Nov 3, 2026Current
510(k) clearances319Nov 8, 2026File dated Nov 2, 2026Current
Inspections3Nov 11, 2026Newest record Nov 5, 2026Current
Compliance actions0Nov 2, 2026Newest record Oct 29, 2026Current

Recent FDA Inspections

DateSiteProductClassificationFEI
May 16, 2025Steenvoorde, FranceBiologicsVoluntary Action Indicated (VAI)3003992026
Feb 6, 2014Steenvoorde, FranceDevicesVoluntary Action Indicated (VAI)3003992026
Aug 6, 2009Steenvoorde, FranceDevicesNo Action Indicated (NAI)3003992026

NAI means no objectionable conditions or practices were found during the inspection. VAI means objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action. OAI means regulatory and/or administrative actions are recommended.

FDA-Inspected Facilities

FacilityLocationInspectionsLatest
FEI 3003992026Steenvoorde, France3May 16, 2025

Recent 510(k) Clearances

K-NumberDeviceDate
K171061MRSASelect IIDec 28, 2017
K122187VRESELECT CULTURE MEDIUMNov 6, 2012
K103684VRESELECT CULTURE MEDIUMOct 21, 2011
K093678PLATELIA ASPERGILLUS EIA MODEL 62793Jan 13, 2011
K100589MRSA SELECT - SKIN AND SOFT TISSUE WOUND SPECIMENSOct 29, 2010
K081362PLATELIA LYME IGMJun 26, 2008
K081212MRSASELECT - EXTENDED INCUBATIONJun 13, 2008
K080012PLATELIA LYME IGG ASSAYMay 8, 2008
K070361MRSASELECTSep 13, 2007
K060641PLATELIA ASPERGILLUS EIA, MODEL 62793Jun 2, 2006
K052838LIQUICHEK DIABETES CONTROL, LEVEL 1,2,3,4Nov 9, 2005
K052053LIQUICHEK QUALITATIVE URINE TOXICOLOGY CONTROL, NEGATIVE, POSITIVE, MINIPAKAug 9, 2005
K050537LIQUICHEK CARDIAC MARKERS PLUS CONTROL, LIQUICHEK CARDIAC MARKERS PLUS CONTROL LT, LIQUICHEK CARDIAC…Apr 27, 2005
K050536QUEST DIAGNOSTICS IMMUNOASSAY/TDM CONTROLMar 24, 2005
K043208LIQUID ASSAYED MULTIQUAL CONTROLJan 7, 2005
K042865LIQUICHEK URINE TOXICOLOGY CONTROL, (LEVELS S1S AND S2S)Nov 24, 2004
K042836LIQUICHEK RETICULOCYTE CONTROL (A)Nov 5, 2004
K042815QUEST TUMOR MARKER CONTROL, MODEL 955Nov 5, 2004
K042837LIQUICHEK ELEVATED CRP CONTROLNov 2, 2004
K042324LYPHOCHEK ELEVATED IMMUNOSUPPRESSANT CONTROL, LEVEL 4, 5Oct 7, 2004

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.